| Mar 2024 | Apr 2023 | Apr 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | ||
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||||
| Cost of Revenue | |||||||||
| Gross Profit | |||||||||
| Gross Profit Margin (%) | |||||||||
| R&D Expense | |||||||||
| SG&A Expense | |||||||||
| Total Operating Expenses | |||||||||
| Operating Income or Loss | |||||||||
| Operating Margin (%) | |||||||||
| Interest Expense | |||||||||
| Total Other Income/Expenses | |||||||||
| Income Before Tax | |||||||||
| Income Tax Expense | |||||||||
| Income from Continuing Ops. | |||||||||
| Net Income | |||||||||
| Net Profit Margin (%) | |||||||||
| Net Income Available to Common Shareholders | |||||||||
| Basic EPS | |||||||||
| Diluted EPS | |||||||||
| Basic Average Shares | |||||||||
| Diluted Average Shares |
| Mar 2024 | Apr 2023 | Apr 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | ||
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||||
| Cost of Revenue | |||||||||
| Gross Profit | |||||||||
| Gross Profit Margin (%) | |||||||||
| R&D Expense | |||||||||
| SG&A Expense | |||||||||
| Total Operating Expenses | |||||||||
| Operating Income or Loss | |||||||||
| Operating Margin (%) | |||||||||
| Interest Expense | |||||||||
| Total Other Income/Expenses | |||||||||
| Income Before Tax | |||||||||
| Income Tax Expense | |||||||||
| Income from Continuing Ops. | |||||||||
| Net Income | |||||||||
| Net Profit Margin (%) | |||||||||
| Net Income Available to Common Shareholders | |||||||||
| Basic EPS | |||||||||
| Diluted EPS | |||||||||
| Basic Average Shares | |||||||||
| Diluted Average Shares |
| Mar 2024 | Apr 2023 | Apr 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | ||
|---|---|---|---|---|---|---|---|---|---|
| Current Assets | |||||||||
| Cash & Cash Equivalents | |||||||||
| Marketable Securities | |||||||||
| Receivables | |||||||||
| Inventories | |||||||||
| Other Current Assets | |||||||||
| Total Current Assets | |||||||||
| Non-Current Assets | |||||||||
| Marketable Securities | |||||||||
| PPE Net | |||||||||
| Intangibles inc. Goodwill | |||||||||
| Other Non-Current Assets | |||||||||
| Total Non-Current Assets | |||||||||
| Total Assets | |||||||||
| Current Liabilities | |||||||||
| Accounts Payable | |||||||||
| Deferred Revenues | |||||||||
| Debt, Current | |||||||||
| Accrued Liabilities | |||||||||
| Other Current Liabilities | |||||||||
| Total Current Liabilities | |||||||||
| Non-Current Liabilities | |||||||||
| Deferred Revenues | |||||||||
| Debt, Non-Current | |||||||||
| Other Non-Current Liabilities | |||||||||
| Total Non-Current Liabilities | |||||||||
| Total Liabilities | |||||||||
| Shareholders' Equity | |||||||||
| Common Stock | |||||||||
| Additional Paid-In Capital | |||||||||
| Retained Earnings | |||||||||
| Other Shareholders' Equity | |||||||||
| Total Shareholders' Equity | |||||||||
| Total Liabilities & Shareholders' Equity |
| Mar 2024 | Apr 2023 | Apr 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | ||
|---|---|---|---|---|---|---|---|---|---|
| Current Assets | |||||||||
| Cash & Cash Equivalents | |||||||||
| Marketable Securities | |||||||||
| Receivables | |||||||||
| Inventories | |||||||||
| Other Current Assets | |||||||||
| Total Current Assets | |||||||||
| Non-Current Assets | |||||||||
| Marketable Securities | |||||||||
| PPE Net | |||||||||
| Intangibles inc. Goodwill | |||||||||
| Other Non-Current Assets | |||||||||
| Total Non-Current Assets | |||||||||
| Total Assets | |||||||||
| Current Liabilities | |||||||||
| Accounts Payable | |||||||||
| Deferred Revenues | |||||||||
| Debt, Current | |||||||||
| Accrued Liabilities | |||||||||
| Other Current Liabilities | |||||||||
| Total Current Liabilities | |||||||||
| Non-Current Liabilities | |||||||||
| Deferred Revenues | |||||||||
| Debt, Non-Current | |||||||||
| Other Non-Current Liabilities | |||||||||
| Total Non-Current Liabilities | |||||||||
| Total Liabilities | |||||||||
| Shareholders' Equity | |||||||||
| Common Stock | |||||||||
| Additional Paid-In Capital | |||||||||
| Retained Earnings | |||||||||
| Other Shareholders' Equity | |||||||||
| Total Shareholders' Equity | |||||||||
| Total Liabilities & Shareholders' Equity |
| Mar 2024 | Apr 2023 | Apr 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | ||
|---|---|---|---|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||||||
| Net Income | |||||||||
| Depreciation & Amortization | |||||||||
| Deferred Income Taxes | |||||||||
| Stock Based Compensation | |||||||||
| Accounts Receivable | |||||||||
| Inventory | |||||||||
| Accounts Payable | |||||||||
| Deferred Revenue | |||||||||
| Other Non-Cash | |||||||||
| Operating Cash Flow | |||||||||
| Cash Flows from Investing Activities | |||||||||
| PPE Investments | |||||||||
| Net Acquisitions | |||||||||
| Purchase of Investments | |||||||||
| Sale of Investments | |||||||||
| Other Investing Activity | |||||||||
| Investing Cash Flow | |||||||||
| Cash Flows from Financing Activities | |||||||||
| Debt Issued | |||||||||
| Proceeds from Debt Repayment | |||||||||
| Debt Repayment | |||||||||
| Proceeds from Sale of Equity | |||||||||
| Equity Repurchased | |||||||||
| Dividend Paid | |||||||||
| Other Financing Activity | |||||||||
| Financing Cash Flow | |||||||||
| Cash Position | |||||||||
| Beginning Cash Position | |||||||||
| End Cash Position | |||||||||
| Change in Cash | |||||||||
| Free Cash Flow | |||||||||
| Operating Cash Flow | |||||||||
| Capital Expenditure | |||||||||
| Free Cash Flow |
| Mar 2024 | Apr 2023 | Apr 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | ||
|---|---|---|---|---|---|---|---|---|---|
| Cash Flows from Operating Activities | |||||||||
| Net Income | |||||||||
| Depreciation & Amortization | |||||||||
| Deferred Income Taxes | |||||||||
| Stock Based Compensation | |||||||||
| Accounts Receivable | |||||||||
| Inventory | |||||||||
| Accounts Payable | |||||||||
| Deferred Revenue | |||||||||
| Other Non-Cash | |||||||||
| Operating Cash Flow | |||||||||
| Cash Flows from Investing Activities | |||||||||
| PPE Investments | |||||||||
| Net Acquisitions | |||||||||
| Purchase of Investments | |||||||||
| Sale of Investments | |||||||||
| Other Investing Activity | |||||||||
| Investing Cash Flow | |||||||||
| Cash Flows from Financing Activities | |||||||||
| Debt Issued | |||||||||
| Proceeds from Debt Repayment | |||||||||
| Debt Repayment | |||||||||
| Proceeds from Sale of Equity | |||||||||
| Equity Repurchased | |||||||||
| Dividend Paid | |||||||||
| Other Financing Activity | |||||||||
| Financing Cash Flow | |||||||||
| Cash Position | |||||||||
| Beginning Cash Position | |||||||||
| End Cash Position | |||||||||
| Change in Cash | |||||||||
| Free Cash Flow | |||||||||
| Operating Cash Flow | |||||||||
| Capital Expenditure | |||||||||
| Free Cash Flow |
